Chief Financial Officer
Joyce LaViscount brings over 30 years of pharma experience spanning start-up organizations to Fortune 100 companies with diverse leadership roles across finance, accounting, and operations. She previously served as CFO for Pananvance Therapeutics, a clinical stage pharma company focused on a novel oncology therapeutic. Her experience includes raising strategic capital to fund corporate development in both private and public company settings. Joyce’s foundation in the industry is based on 20 years of increasing responsibilities with Pfizer/Pharmacia, Bristol-Myers Squibb, and Endo Pharmaceuticals.